Multistage pH-responsive liposomes for mitochondrial-targeted anticancer drug delivery.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 22678851.
- Also identified by DOI 10.1002/adma.201201498.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Zwitterionic oligopeptide liposomes (HHG2C(18)-L) containing a smart lipid (1,5-dioctadecyl-L-glutamyl 2-histidyl-hexahydrobenzoic acid, HHG2C(18)) are developed to overcome the barriers faced by anticancer drugs on the route from the site of injection into the body to the final antitumor target within transport steps with multiple physiological and biological barriers. HHG2C(18)-L show the multistage pH-responsive to the tumor cell (the mitochondria in this case). Their multistage pH response leads to more effective entry of the tumor cell, improved escape from the endolysosomes, and accumulation at the mitochondria (see picture).
Medical subject headings
- Antineoplastic Agents
- Liposomes
- Mitochondria